Integrating techniques
to improve human health, risk assessment, and drug safety: combining systems toxicology, pharmacology, and OMICS approaches.
Physiologically-based (pharmaco)kinetic modeling
of internal exposure to drugs and environmental chemicals, focusing on lifestage modeling and inter-individual variability.
Computational neurobiology and transcriptomics
to study neurotoxic and neurodevelopmental endpoints: combining physiologically-based models, differential gene expression analysis, and in vitro data.
